A Double-Blinded, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Uncontrolled Type 2 DM Subjects on Diet Control Alone, Metformin Monotherapy, or Two or Three Oral Glucose-lowering Agents
Latest Information Update: 06 Mar 2023
At a glance
- Drugs Insulin (Primary) ; Antihyperglycaemics; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Apr 2021 New trial record